Abiopharma

News list

Director Dugle Lynn A 🟢 acquired 105 shares of KBR, INC. (KBR) at $36.70 Transaction Date: Apr 15, 2026 | Filing ID: 000129

Full text

News bot April 16, 2026, 10:42 p.m.
🔍 Dugle Lynn A (Director)

Company: KBR, INC. (KBR)

Report Date: 2026-04-15
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 105
Detailed Transactions and Holdings:
- Acquired 105 shares of Common Stock at $36.7 per share (Direct)
  Date: 2026-04-15 | Code: A | equity_swap_involved: 0 | shares_owned_after: 28,281.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Shares acquired under dividend reinvestment in the Directors' deferred compensation plan.